Study,Study Country,Study Site,Subject,Event Group Label,Event Group Name,Event Group Sequence Number,Event Label,Event Name,Event Date,Form Casebook Version,Form Label,Form Name,Form Sequence Number,Form Status,Datetime of Form Creation,Form First Submission Date,Form Last Submission Date,Form ILB Status,Form ILB Reason,Item Group Sequence Number,Datetime of Last Data Change,Data Listing As Of,Opened Queries,Closed Queries,Study treatment name (ig_EC_F.ECTRT1),Dose form (ig_EC_F.ECDOSFRM1),Visit (ig_EC_F.VISIT2),1. Date (ig_EC_F.ECSTDAT_SINGLE),1. Date (ig_EC_F.ECSTDAT_SINGLE)_RAW,2. Time (ig_EC_F.ECSTTIM_SINGLE),3a. Dose (ig_EC_F.ECDSTXT2),3b. Kit number (ig_EC_F.ECREFID),4. Unit (ig_EC_F.ECDOSU1),5. Route (ig_EC_F.ECROUTE1),Location of administration (ig_EC_F.ECLOC),"6. If dose adjusted, reason (ig_EC_F.ECADJ1)",Form SDV Status,Form SDV Datetime,Form DMR Status,Form DMR Datetime,Form Frozen Status,Form Frozen Datetime,Form Locked Status,Form Locked Datetime,Form Signed Status,Form Signed Datetime
M20-371_DEV1,India,1001,SCR-0001,Primary_1,eg_primary_1,1,Study Treatment Administration,STA,2024-08-06,1,Study Treatment Administration - SC,EC_F,1,Submitted,2025-09-16 06:16:13 UTC,,2025-09-16 06:20:44 UTC,false,,1,2025-09-16 06:20:43 UTC,2025-09-16 07:03:19 UTC,1,0,ABT 154,"INJECTION, SOLUTION",Induction Week 6,2025-06-10,10-Jun-2025,10:00,1.5,,mg,Intravenous,Abdominal region,Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
